文献速递其他结缔组织病

DETECT算法在系统性硬化症队列中筛查肺动脉高压的表现

Performance of the DETECT Algorithm for Pulmonary Hypertension Screening in a Systemic Sclerosis Cohort.
PubMed 文献 · Arthritis Rheumatol · 2021-07-27

本研究评估DETECT算法与2015年ESC/ERS指南在系统性硬化症(SSc)患者中筛查肺动脉高压(PH)的预测准确性。DETECT算法敏感性为1.00(95%CI 0.69-1.00),阴性预测值(NPV)为1.00(95%CI 0.80-1.00);2015年ESC/ERS指南敏感性为0.80(95%CI 0.44-0.97),NPV为0.94(95%CI 0.81-0.99)。在DLco≥60%预测值亚组中,DETECT算法亦显示高敏感性和NPV。

要点

  • DETECT算法在SSc患者中诊断PAH敏感性达1.00,NPV达1.00。
  • 2015年ESC/ERS指南敏感性为0.80,NPV为0.94。
  • DLco≥60%预测值亚组中DETECT算法敏感性仍为1.00。

核心结论

  • DETECT算法对SSc患者PAH诊断具有高敏感性和阴性预测值,包括DLco≥60%预测值的个体。

研究设计与样本

  • 纳入接受诊断性RHC、无PH或PAH、且DETECT与2015年ESC/ERS指南所需变量数据可用的SSc患者进行分析。
  • PH分类基于2018年修订标准血流动力学和高分辨率计算机断层扫描所示肺纤维化范围。

主要发现

  • DETECT算法敏感性为1.00(95%CI 0.69-1.00),NPV为1.00(95%CI 0.80-1.00)。
  • 2015年ESC/ERS指南敏感性为0.80(95%CI 0.44-0.97),NPV为0.94(95%CI 0.81-0.99)。
  • DLco≥60%预测值患者(n=27)中,DETECT算法敏感性为1.00(95%CI 0.29-1.00),NPV为1.00(95%CI 0.59-1.00)。
  • DLco≥60%预测值患者中,2015年ESC/ERS指南敏感性为0.67(95%CI 0.09-0.99),NPV为0.94(95%CI 0.71-1.00)。

临床怎么用

  • 在SSc患者中可考虑使用DETECT算法进行PAH筛查,因其高敏感性和NPV有助于排除PAH。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Pulmonary arterial hypertension (PAH) is one of the leading causes of mortality in systemic sclerosis (SSc). This study was undertaken to assess predictive accuracies of the DETECT algorithm and the 2015 European Society of Cardiology/European Respiratory Society (ESC/ERS) guidelines in SSc patients who underwent right-sided heart catheterization (RHC) for pulmonary hypertension (PH) evaluation. METHODS: Patients with SSc who had diagnostic RHC, had no PH or had PAH, and had available data on variables to allow application of the DETECT and 2015 ESC/ERS guidelines were included for analysis. PH classification was based on hemodynamics using the 2018 revised criteria and extent of lung fibrosis shown on high-resolution computed tomography. Sensitivity and predictive accuracies of the DETECT algorithm and 2015 ESC/ERS guidelines were calculated, including analysis of subjects with a diffusing capacity for carbon monoxide (DLco) of ≥60% predicted. RESULTS: Sixty-eight patients with SSc had RHC, of whom 58 had no PH and 10 had PAH. The mean age was 60.0 years, and 58.8% had limited cutaneous SSc. The DETECT algorithm had a sensitivity of 1.00 (95% confidence interval [95% CI] 0.69-1.00) and a negative predictive value (NPV) of 1.00 (95% CI 0.80-1.00), whereas the 2015 ESC/ERS guidelines had a sensitivity of 0.80 (95% CI 0.44-0.97) and an NPV of 0.94 (95% CI 0.81-0.99). In patients with a DLco of ≥60% (n = 27), the DETECT algorithm had a sensitivity of 1.00 (95% CI 0.29-1.00) and an NPV of 1.00 (95% CI 0.59-1.00), whereas the 2015 ESC/ERS guidelines had a sensitivity of 0.67 (95% CI 0.09-0.99) and an NPV of 0.94 (95% CI 0.71-1.00). CONCLUSION: The DETECT algorithm has high sensitivity and NPV for diagnosis of PAH, including among individuals with a DLco of ≥60%.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Young A, Moles VM, Jaafar S, et al. Performance of the DETECT Algorithm for Pulmonary Hypertension Screening in a Systemic Sclerosis Cohort. Arthritis Rheumatol. 2021. PMID: 33760392. doi:10.1002/art.41732

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。